MRI-based tumour control probability in skull-base chordomas treated with carbon-ion therapy.

[1]  P. Keall,et al.  Medical physics challenges in clinical MR-guided radiotherapy , 2020, Radiation oncology.

[2]  M. Li,et al.  MRI Signal Intensity and Electron Ultrastructure Classification Predict the Long-Term Outcome of Skull Base Chordomas , 2020, American Journal of Neuroradiology.

[3]  C. Karger,et al.  Radiobiological issues in prospective carbon ion therapy trials , 2018, Medical physics.

[4]  K. Winter,et al.  Whole lesion histogram analysis of meningiomas derived from ADC values. Correlation with several cellularity parameters, proliferation index KI 67, nucleic content, and membrane permeability. , 2018, Magnetic resonance imaging.

[5]  F. Valvo,et al.  MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  A. Bel,et al.  The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies , 2018, Radiation Oncology.

[7]  S. Sullivan,et al.  UM-Chor1: establishment and characterization of the first validated clival chordoma cell line. , 2017, Journal of neurosurgery.

[8]  M. Zou,et al.  Prognostic Factors in Skull Base Chordoma: A Systematic Literature Review and Meta-Analysis. , 2018, World neurosurgery.

[9]  C. Karger,et al.  RBE and related modeling in carbon-ion therapy , 2017, Physics in medicine and biology.

[10]  K. Herfarth,et al.  Diffusion‐weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique , 2017, Journal of magnetic resonance imaging : JMRI.

[11]  A. Nahum,et al.  Increasing the power of tumour control and normal tissue complication probability modelling in radiotherapy: recent trends and current issues , 2017 .

[12]  Marco Durante,et al.  Charged-particle therapy in cancer: clinical uses and future perspectives , 2017, Nature Reviews Clinical Oncology.

[13]  Jiang Du,et al.  Prognostic Value of a Category Based on Electron Microscopic Features of Clival Chordomas. , 2017, World neurosurgery.

[14]  J. Mizoe.  Review of carbon ion radiotherapy for skull base tumors (especially chordomas). , 2016, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[15]  Ludvig Paul Muren,et al.  A tumour control probability model for radiotherapy of prostate cancer using magnetic resonance imaging-based apparent diffusion coefficient maps. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  G. Jiang,et al.  The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC) , 2016, Journal of Cancer Research and Clinical Oncology.

[17]  P. Lambin,et al.  A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy. , 2016, Medical physics.

[18]  O. Bayrak,et al.  The molecular aspects of chordoma , 2016, Neurosurgical Review.

[19]  Maria A Schmidt,et al.  Radiotherapy planning using MRI , 2015, Physics in medicine and biology.

[20]  Bengt K. Lind,et al.  Impact of Dose and Sensitivity Heterogeneity on TCP , 2014, Comput. Math. Methods Medicine.

[21]  Matthew M. Pearson,et al.  Diffusion-Weighted MRI: Distinction of Skull Base Chordoma from Chondrosarcoma , 2013, American Journal of Neuroradiology.

[22]  M. Uesaka,et al.  Comparison of human chordoma cell-kill for 290 MeV/n carbon ions versus 70 MeV protons in vitro , 2013, Radiation Oncology.

[23]  M. Durante,et al.  Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation , 2012, Journal of radiation research.

[24]  Mahlon D. Johnson,et al.  Diffusion-weighted imaging for differentiating benign from malignant skull lesions and correlation with cell density. , 2012, AJR. American journal of roentgenology.

[25]  Philippe Lambin,et al.  Functional MRI for radiotherapy dose painting. , 2012, Magnetic resonance imaging.

[26]  Issam El Naqa,et al.  Monte Carlo role in radiobiological modelling of radiotherapy outcomes , 2012, Physics in medicine and biology.

[27]  B. Nahed,et al.  Chordoma: current concepts, management, and future directions. , 2012, The Lancet. Oncology.

[28]  D. Schulz‐Ertner.  Chordomas and Chondrosarcomas: Treatment with Particle Radiotherapy , 2012 .

[29]  Harald Paganetti,et al.  Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Dieter Schardt,et al.  Heavy-ion tumor therapy: Physical and radiobiological benefits , 2010 .

[31]  T. Kawase,et al.  Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy , 2009, Acta Neurochirurgica.

[32]  Wayne D. Newhauser,et al.  International Commission on Radiation Units and Measurements Report 78: Prescribing, Recording and Reporting Proton-beam Therapy , 2009 .

[33]  A. Nahum,et al.  Biological Evaluation of Treatment Plans , 2007 .

[34]  Michael Scholz,et al.  Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. , 2007, International journal of radiation oncology, biology, physics.

[35]  P. Stavrev,et al.  Derivation of the expressions for gamma50 and D50 for different individual TCP and NTCP models. , 2002, Physics in medicine and biology.

[36]  J. Deasy,et al.  Uncertainties in model-based outcome predictions for treatment planning. , 2001, International journal of radiation oncology, biology, physics.

[37]  S Webb,et al.  A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. , 1993, Physics in medicine and biology.

[38]  A. E. Nahum,et al.  Maximizing Local Control by Customized Dose Prescription for Pelvic Tumours , 1992 .

[39]  J. Fowler.  The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.